Last reviewed · How we verify
NCT04194424
A Multidisciplinary Weight Loss Program at AUB-MC
NA trial testing Multidisciplinary weight loss program in Obesity in 20 participants. Participants enrolled and being followed up; not accepting new ones.
15 September 2026
Quick facts
| Lead sponsor | American University of Beirut Medical Center |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 15 August 2023 |
| Primary completion | 15 September 2026 |
| Estimated completion | 15 September 2026 |
| Sites | 1 location across Lebanon |
Drugs / interventions tested
- Multidisciplinary weight loss program
- Standard Care — full drug profile →
- Metformin Hcl 850Mg Tab
Conditions studied
- Obesity — all drugs for Obesity →
- Weight Loss — all drugs for Weight Loss →
Sponsor
American University of Beirut Medical Center
Who can join
18 and older, any sex, with Obesity or Weight Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The current project aims at evaluating the feasibility and efficacy of a multi-disciplinary weight loss program, using an innovative and simple dietary intervention at the American University of Beirut Medical Center (AUB-MC). Such intervention is expected to enhance patients' compliance and adherence to lifestyle changes. In addition, the program includes supervised exercise sessions and behavioral therapy. Therefore, our project proposes an evidence based approach to close the obesity treatment gaps.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04194424
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other American University of Beirut Medical Center trials
Trials by the same sponsor.
- NCT07387848 — Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lym · Phase 2 · not yet recruiting
- NCT07111000 — Testing the Epley Maneuver for Treating Dizziness in the Emergency Department: A Randomized Study · NA · not yet recruiting
- NCT07059624 — Femoral Arterial Cannulation in Pediatrics · NA · recruiting
- NCT06777875 — COMT and OPRM1 Polymorphisms and Their Effect on Post-Operative Pain in Children · recruiting
- NCT06815952 — Enhancing Difficult Laryngoscopy Prediction Through A Mixed Scoring System · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04194424 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by American University of Beirut Medical Center
- Last refreshed: 29 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04194424.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing